Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-03-18

FDA Approved: MIRTAZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Mylan Pharmaceuticals' generic mirTAZAPine (mirtazapine).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)